Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01630525

NCT01630525
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You must be older than 60 years of age
  • You must have good enough vision (with glasses or contacts if needed) to see clearly with both eyes
  • You must be willing and able to sign a consent form agreeing to take part
  • You must be covered by French Social Security

If you have early-stage (prodromal) Alzheimer's (Group A):

  • You have concerns about your memory
  • Your ability to carry out daily tasks is normal or only very slightly affected
  • You show a specific pattern of memory difficulties identified through testing (confirm with trial site)
  • Your score on a standard memory and thinking test (CDR) is 0.5 or above
  • Your memory problems have lasted more than 3 months
  • Your overall thinking and reasoning is still largely intact (MMSE score of 24 or above)
  • Other possible causes of your memory problems have been ruled out
  • You have had a brain scan (MRI) showing little or no significant shrinkage in memory-related brain areas

If you have typical mild to moderate Alzheimer's (Group B):

  • You have been formally diagnosed with Alzheimer's disease using standard medical criteria
  • Your score on a standard thinking and memory test (MMSE) is 20 or above

If you are a healthy volunteer (Group C):

  • You have no significant concerns about your memory or thinking
  • Your score on a standard thinking and memory test (MMSE) is 24 or above

Who may not be able to join:

  • Anyone with a significant vision problem that cannot be corrected with glasses
  • Anyone with eye movement problems or a squint (where the eyes do not align properly)
  • Anyone currently being treated for depression
  • Anyone who is unable to give their own consent to participate
  • Healthy volunteers who have any memory or thinking concerns
  • Healthy volunteers whose thinking or memory tests at the first visit suggest any cognitive difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Bordeaux
Registry
clinicaltrials_gov
Start date
1 December 2012
Est. completion
1 December 2015

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Saccades execution parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov